Table 1.
DEMOGRAPHIC VARIABLES | |
---|---|
Males, N° (%) | 25 (73.5) |
Age, years; median (IQR) | 72 (63.5-78) |
Days of enrolment after onset of symptoms; median (IQR) a | 4 (2-8) |
N° (%) of subjects with nosocomial acquisition | 2 (5.9) |
N° (%) of subjects with contacts with suspected or confirmed COVID-19 cases | 13 (38.2) |
CLINICAL VARIABLES | |
Charlson co-morbidity index, median (IQR) | 6 (5-7.8) |
N (%) of subjects with underlying chronic disease: | |
- with hypertension - with cardio-vascular disease - with diabetes mellitus - with chronic kidney disease (CKD) - with chronic obstructive pulmonary disease (COPD) - with liver cirrhosis | 19 (55.9) 14 (41.2) 9 (26.5) 8 (23.5) 6 (17.6) 2 (5.9) |
MALIGNANCY VARIABLES | |
Type of cancer, N° (%) | |
- Prostatic cancer - Colon cancer - Breast cancer - Lung cancer - Gastric cancer - Pancreatic cance - Melanoma - Liver cancer - Lymphoma - Myeloma - Leukemia - Womb cancer - Other - Not available | 6 (17.6) 5 (14.7) 1 (2.9) 4 (11.8) 1 (2.9) 2 (5.9) 1 (2.9) 1 (2.9) 3 (8.8) 1 (2.9) 2 (5.9) 1 (2.9) 2 (5.9) 4 (11.8) |
State of cancer disease, N° (%) b: | |
- in treatment - off-therapy - in post-treatment follow-up | 12 (35.3) 5 (14.7) 12 (35.3) |
History of previous cancer treatment, N° (%): | |
- Surgery - Surgery in the previous 30 days - Chemotherapy - Chemotherapy in the last 30 days - Radiotherapy - Radiotherapy in the last 30 days - Immuno/Target-therapy - Immuno/Target-therapy in the last 30 days | 14 (41.2) 5 11 (32.6) 4 5 (14.7) 1 2 (5.9) 2 |
a: not available data for 9 subjects; b: not available data for 5 subjects.